Skip to content
WHO: No Time to Wait: Securing the future from drug-resistant infections
Read more…
US FDA and Health Canada Joint Regional Consultation on the International Council for Harmonisation (ICH)
Read more…
CDSCO: Frequently Asked Questions (FAQs) on New Drugs and Clinical Trials
Read more…
CDE Shares Chinese Medicine Clinical Research Guidelines for Consultation (article in Chinese)
Read more…
TGA: Labelling Changes, information for health professionals
Read more…
EMA: Two additional countries to benefit from EU-US mutual recognition agreement for inspections
Read more…
EMA: Questions & Answers on the impact of Mutual Recognition Agreement between the European Union and the United States as of 30 April 2019
Read more…
Health Canada: Supporting evidence for implantable medical devices manufactured by 3D printing
Read more…
CDER: New Drugs Regulatory Program Modernization
Read more…
JAMA Study Reinforces FDA’s Call to Further Test Sunscreens
Read more…
China Reviews Supervision of Cell and Gene Therapies Through Regulatory Action Plan (article in Chinese)
Read more…
FDA to Study DTC Ads for Drugs Approved Under Accelerated Process
Read more…
FDA Finalizes Two Guidance’s to Align X-Ray Imaging Devices With International Standards
Read more…
List Prices in Drug Ads on TV Coming as CMS Finalizes Rule
Read more…
RWE Submissions: FDA Drafts Guidance
Read more…
Clinical Lactation Studies: Considerations for Study Design Guidance for Industry
Read more…
Post-approval Pregnancy Safety Studies Guidance for Industry
Read more…
France’s ANSM Addresses Cell and Gene Therapies in Revisions to GMP Guide (article in French)
Read more…
Oncology Pharmaceuticals: Reproductive Toxicity Testing and Labelling Recommendations Guidance for Industry
Read more…
FDA Finalizes Maximal Usage Trials Guidance for Topical OTC Drugs
Read more…
ICH: GENERAL CONSIDERATIONS FOR CLINICAL STUDIES
Read more…
FDA: Determining Whether to Submit an ANDA or a 505(b)(2) Application
Read more…
MAPP Describes the Work of CDER’s Biopharmaceutics Council
Read more…
FDA: Considerations in Demonstrating Interchangeability with a Reference Product
Read more…
Health Canada: Drafts Policies for Special Access to Medicines Program
Read more…
Study Finds Few Voluntary Post-approval Trials for First Approved Indication
Read more…
China’s Drug Regulator Tightens Ties to Agencies in Hong Kong and Macau (article in Chinese)
Read more…
FDA: OPQ Reports on State of Drug Quality in FY2018
Read more…
European Commission Confirms Quality of South Korean Active Substances
Read more…
FDA Unveils 34 New and Revised Product-Specific Draft Guidances
Read more…
Reassessing Benefit-Risk: FDA Preps for New Guidance
Read more…
WHO Stresses Role of GMP in Combatting Antimicrobial Resistance
Read more…
Health Canada: Final report, fees for Drugs and Medical Devices
Read more…
Health Canada: Performance Standards for the fees in respect of drugs and medical devices order
Read more…
FDA: Patient Use of Unapproved Diabetes Management Devices Poses Insulin Dosing Risks
Read more…
FDA: Considerations in Demonstrating Interchangeability with a Reference Product
Read more…
UK Clinical Trial Pilot Helps Companies Prep for New EU Regulation
Read more…
CDSCO India Assigns Risk Categories to Imaging Scanners, Other Recategorized Devices
Read more…
TGA Stops Sending Reminders About Device Annual Reporting Requirements
Read more…
PH FDA QUALIFIES AS 5th ASEAN INSPECTION SERVICE
Read more…
US FDA: Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Other Quality-Related Considerations
Read more…
ICMRA: Drug Regulators Look to Harmonize How They Tackle Innovation
Read more…
TÜV SÜD Becomes Second NB to be Designated Under EU MDR
Read more…
EU Report Highlights Challenges of Regulating AI and Robotics in Healthcare
Read more…
HPRA: Guide to New applications and variations to Manufacturer’s Authorisations
Read more…
Like this:
Like Loading...